泰林生物(300813.SZ)发布上半年业绩，归母净利润1354.29万元，增长105.76%

Group 1 - The company reported a revenue of 146 million yuan for the first half of 2025, representing a year-on-year decrease of 6.69% [1] - The net profit attributable to shareholders of the listed company was 13.54 million yuan, showing a year-on-year increase of 105.76% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 13.20 million yuan, reflecting a year-on-year growth of 116.80% [1] Group 2 - The basic earnings per share were 0.11 yuan [1] - The company proposed a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders [1]